Spots Global Cancer Trial Database for Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
Official Title: A Phase 2 Study of Vinblastine Sulphate Injection in Children With Recurrent or Refractory Low Grade Glioma
Study ID: NCT00213278
Conditions
Interventions
Study Description
Brief Summary: This study is examining whether Vinblastine is an effective drug to shrink low grade glioma brain tumors in children, and what the side effects are.
Detailed Description:
Eligibility
Minimum Age: 1 Day
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Hospital for Sick Children, Toronto, Ontario, Canada
Contact Details
Name: Eric Bouffet, MD
Affiliation: The Hospital for Sick Children, Toronto Canada
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
